GoldenGolden
Mind Medicine, Inc.

Mind Medicine, Inc.

Toronto-based company developing drugs for use in psychedelic therapy protocols.

All edits

Edits on 21 Oct, 2020
Aime Anne Nisay"Approved suggestion #877711"
Aime Anne Nisay edited on 21 Oct, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
CEO
Jamon Rahn
Former CEO
Aime Anne Nisay
Aime Anne Nisay edited on 21 Oct, 2020
Edits made to:
Infobox (+2 properties)
Edits on 7 Aug, 2020
Erin Scherfner"Research engine edit"
Erin Scherfner edited on 7 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Founded date
2019
Edits on 3 Aug, 2020
Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Date incorporated
2010
Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
People (+10 rows) (+20 cells) (+452 characters)
People

Name
Role
LinkedIn

Carol Nast

Chief Operating Officer

Collin Gage

Head of Corporate Development

Dave Guebert

Chief Financial Officer

Donald Gehlert, PhD

Chief Scientific Officer

Jamon Rahn

Co-Founder, Director & Co-CEO

Jeanne Bonelle

EVP, Technical Operations

Madeline Feldman

Director of Operations & Administration

Nico Forte

Senior Director, Business Operations and Development

Scott Freeman, MD

Co-Founder, Chief Medical Officer

Stephen L. Hurst, JD

Co-Founder, Executive Chair & Co-CEO

Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Infobox (+7/--1 properties)
Infobox
CEO
Legal name
Mind Medicine Inc.
Company status
Active
Edits on 19 Jul, 2020
Edita Rexha
Edita Rexha approved a suggestion from Golden's AI on 19 Jul, 2020
Edits made to:
Article (+13/-13 characters)
Article

Mind Medicine (MindMed) Inc. announced that in collaboration with University Hospital Basel's Liechti Laboratory, it has discovered and filed a patent application in the United StatesUnited States (preserving all worldwide rights) for a neutralizer technology intended to shorten and stop the effects of an LSD trip during a therapy session.

Edits on 26 Jun, 2020
Jason D. Rowley
Jason D. Rowley edited on 26 Jun, 2020
Edits made to:
Description (+80 characters)
Topic thumbnail

Mind Medicine, Inc.

Toronto-based company developing drugs for use in psychedelic therapy protocols.

Jason D. Rowley"Approved suggestion from source: https://twitter.com/mindmedco"
Jason D. Rowley approved a suggestion from Golden's AI on 26 Jun, 2020
Edits made to:
Topic thumbnail

Mind Medicine, Inc.

Toronto-based company developing drugs for use in psychedelic therapy protocols.

Jason D. Rowley"Approved suggestion #855213 from source: http://mindmed.co"
Jason D. Rowley approved a suggestion from Golden's AI on 26 Jun, 2020
Edits made to:
Infobox (+1 properties)
Jason D. Rowley"Approved suggestion #855212 from source: http://mindmed.co"
Jason D. Rowley approved a suggestion from Golden's AI on 26 Jun, 2020
Edits made to:
Infobox (+1 properties)
Jason D. Rowley
Jason D. Rowley edited on 26 Jun, 2020
Edits made to:
Infobox (+4 properties)
Article (+749 characters)
Article

Mind Medicine (MindMed) Inc. announced that in collaboration with University Hospital Basel's Liechti Laboratory, it has discovered and filed a patent application in the United States (preserving all worldwide rights) for a neutralizer technology intended to shorten and stop the effects of an LSD trip during a therapy session.

This discovery, when further developed, may act as the 'off-switch' to an LSD trip.

MindMed is the leading psychedelic pharmaceutical company and the Liechti Laboratory is the leading research center focused on the pharmacology of psychedelic substances.

...

The invention may help reduce the acute effects of a psychedelic drug and help shorten the hallucinogenic effects when required by a patient or medical professional.

Infobox
Edits on 26 Dec, 2019
Golden AI"Updated fields for funding rounds"
Golden AI edited on 26 Dec, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI"Created by Golden AI for: Funding Round"
Golden AI created this topic on 26 Dec, 2019
Edits made to:
Topic thumbnail

 Mind Medicine, Inc.

Toronto-based company developing drugs for use in psychedelic therapy protocols.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.